Stay updated with breaking news from Clinical pipeline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
uniQure Inc.: uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
~ Announced encouraging interim analysis data from ongoing Phase I/II clinical trial of AMT-130 in Huntington’s disease showing preservation of function compared to baseline and clinical benefits. ....
POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top line interim results of a Phase 3 clinical trial of EuCorVac-19 ....
Pluri (NASDAQ:PLUR – Get Rating) and INmune Bio (NASDAQ:INMB – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Profitability This table compares Pluri and INmune Bio’s net margins, […] ....
Pluri (NASDAQ:PLUR – Get Rating) and Vir Biotechnology (NASDAQ:VIR – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Profitability This table compares Pluri and Vir Biotechnology’s net margins, return […] ....